Literature DB >> 11166408

Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.

H S Yoo1, T G Park.   

Abstract

Biodegradable polymeric micelles containing doxorubicin in the core region were prepared from a di-block copolymer composed of doxorubicin-conjugated poly(DL-lactic-co-glycolic acid) (PLGA) and polyethyleneglycol (PEG). The di-block copolymer of PLGA-PEG was first synthesized and the primary amino group of doxorubicin was then conjugated to the terminal hydroxyl group of PLGA, which had been pre-activated using p-nitrophenyl chloroformate. The resulting polymeric micelles in aqueous solution were characterized by measurement of size, drug loading, and critical micelle concentration. The micelles containing chemically-conjugated doxorubicin exhibited a more sustained release profile than PEG-PLGA micelles containing physically-entrapped doxorubicin. The cytotoxic activity of the micelles against HepG2 cells was greater than free doxorubicin, suggesting that the micelles containing conjugated doxorubicin were more effectively taken up cellularly, by an endocytosis mechanism rather than by passive diffusion. Confocal microscopic observation and flow cytometry analysis supported the enhanced cellular uptake of the micelles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166408     DOI: 10.1016/s0168-3659(00)00340-0

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  64 in total

1.  In vivo evaluation of doxorubicin-loaded (PEG)(3)-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDox™.

Authors:  Wubeante Yenet Ayen; Neeraj Kumar
Journal:  Pharm Res       Date:  2012-06-06       Impact factor: 4.200

Review 2.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

3.  Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.

Authors:  Zhuoya Wan; Jingjing Sun; Jieni Xu; Pearl Moharil; Jing Chen; Junchi Xu; Junjie Zhu; Jiang Li; Yixian Huang; Pengfei Xu; Xiaochao Ma; Wen Xie; Binfeng Lu; Song Li
Journal:  Acta Biomater       Date:  2019-03-28       Impact factor: 8.947

4.  In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.

Authors:  Sai H S Boddu; Jwala Jwala; Monica R Chowdhury; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

5.  Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.

Authors:  Ying Wang; David M Lonard; Yang Yu; Dar-Chone Chow; Timothy G Palzkill; Jin Wang; Ruogu Qi; Alexander J Matzuk; Xianzhou Song; Franck Madoux; Peter Hodder; Peter Chase; Patrick R Griffin; Suoling Zhou; Lan Liao; Jianming Xu; Bert W O'Malley
Journal:  Cancer Res       Date:  2014-01-03       Impact factor: 12.701

6.  Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid).

Authors:  Tao Yu; Ying-Ying Wang; Ming Yang; Craig Schneider; Weixi Zhong; Sarah Pulicare; Woo-Jin Choi; Olcay Mert; Jie Fu; Samuel K Lai; Justin Hanes
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

7.  Dual-frequency ultrasound activation of nanomicellar doxorubicin in targeted tumor chemotherapy.

Authors:  Hadi Hasanzadeh; Manijhe Mokhtari-Dizaji; S Zahra Bathaie; Zuhair M Hassan; Amir Ali Shahbazfar
Journal:  J Med Ultrason (2001)       Date:  2013-10-05       Impact factor: 1.314

8.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; Oscar J Santiesteban; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2011-09-27       Impact factor: 15.419

Review 9.  Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.

Authors:  Avinash Gothwal; Iliyas Khan; Umesh Gupta
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

10.  Stability and release performance of a series of pegylated copolymeric micelles.

Authors:  Wen-Jen Lin; Lee-Wei Juang; Chi-Chang Lin
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.